Abstract: To propose an oral cavity sensor capable of analyzing tongue movements in more detail than before. In an oral cavity sensor (1) which is even provided with a sensor element (7) having a mechanical configuration capable of measuring each of external force components in three axis directions, the sensor element (7) can be protected by an elastic body (9), and the whole of the elastic body (9) is covered with the coating film (11a) made of a biocompatible material. Thereby, the sensor element (7) and the elastic body (9) can be safely attached in an oral cavity (MT) of a subject (EXA), and can measure each of the external force components in the three axis directions. As a result, on the basis of the external force components in the three axis directions, complicated tongue movements at the time of mastication or swallowing in the oral cavity (MT) can be analyzed in more detail than before.

Abstract: To propose an oral cavity sensor capable of analyzing tongue movements in more detail than before. In an oral cavity sensor (1) which is even provided with a sensor element (7) having a mechanical configuration capable of measuring each of external force components in three axis directions, the sensor element (7) can be protected by an elastic body (9), and the whole of the elastic body (9) is covered with the coating film (11a) made of a biocompatible material. Thereby, the sensor element (7) and the elastic body (9) can be safely attached in an oral cavity (MT) of a subject (EXA), and can measure each of the external force components in the three axis directions. As a result, on the basis of the external force components in the three axis directions, complicated tongue movements at the time of mastication or swallowing in the oral cavity (MT) can be analyzed in more detail than before.

Abstract: The invention provides a total enteral nutritious composition containing proteins, sugars, fats, minerals and vitamins, which improves serum albumin and ameliorates bedsores. The total enteral nutritious composition has a zinc/copper weight ratio of 10-25, and a zinc content of 1.5 mg or greater, a copper content of 0.075-0.15 mg, a sodium content of at least 185 mg, a vitamin B1 content of at least 0.30 mg, a vitamin B2 content of at least 0.25 mg and a protein content of at least 4.0 g, per 100 kcal of the composition. Preferably it has a protein content of at least 5.0 g, a vitamin B6 content of at least 0.30 mg, a biotin content of at least 1.0 ?g, a vitamin B12 content of at least 0.20 ?g, a folic acid content of at least 20 ?g, a ?-carotene content of at least 100 ?g and a vitamin C content of at least 10 mg. Medium-chain fatty acid oils preferably constitute 35% by weight of the fats of the fat source, per 100 kcal of the composition. The preferred composition viscosity is 6-18 mPa·s (25° C.

Abstract: An iridium-based alloy which has L12-type intermetallic compounds dispersedly precipitated therein and has a basic composition including, in terms of mass proportion, 0.1 to 9.0% Al, 1.0 to 45% W, and Ir as the remainder. The component system containing 0.1 to 1.5% Al has L12-type intermetallic compounds dispersedly precipitated therein. The component system containing 1.5 to 9.0%, excluding 1.5%, Al has L12-type and B2-type intermetallic compounds dispersedly precipitated therein. Part of the Ir may be replaced with an element (X) (Co, Ni, Fe, Cr, Rh, Re, Pd, Pt, or Ru) and part of the Al and W may be replaced with an element (Z) (Ni, Ti, Nb, Zr, V, Ta, Hf, or Mo). The iridium-based alloy, which contains L12-type intermetallic compounds [1r3(Al,W) and [(Ir, X)3(Al, W, Z)] dispersedly precipitated therein, has a high melting point. The lattice constant mismatch between the L12-type intermetallic compounds, i.e.

Abstract: An iridium-based alloy which has Ll2-type intermetallic compounds dispersedly precipitated therein and has a basic composition including, in terms of mass proportion, 0.1 to 9.0% Al, 1.0 to 45% W, and Ir as the remainder. The component system containing 0.1 to 1.5% Al has L12-type intermetallic compounds dispersedly precipitated therein. The component system containing 1.5 to 9.0%, excluding 1.5%, Al has Ll2-type and B2-type intermetallic compounds dispersedly precipitated therein. Part of the Ir may be replaced with an element (X) (Co, Ni, Fe, Cr, Rh, Re, Pd, Pt, or Ru) and part of the Al and W may be replaced with an element (Z) (Ni, Ti, Nb, Zr, V, Ta, Hf, or Mo). The iridium-based alloy, which contains L12-type intermetallic compounds [1r3(Al,W) and [(Ir, X)3(Al, W, Z)] dispersedly precipitated therein, has a high melting point. The lattice constant mismatch between the L12-type intermetallic compounds, i.e.

Abstract: The invention provides a total enteral nutritious composition containing proteins, sugars, fats, minerals and vitamins, which improves serum albumin and ameliorates bedsores. The total enteral nutritious composition has a zinc/copper weight ratio of 10-25, and a zinc content of 1.5 mg or greater, a copper content of 0.075-0.15 mg, a sodium content of at least 185 mg, a vitamin B1 content of at least 0.30 mg, a vitamin B2 content of at least 0.25 mg and a protein content of at least 4.0 g, per 100 kcal of the composition. Preferably it has a protein content of at least 5.0 g, a vitamin B6 content of at least 0.30 mg, a biotin content of at least 1.0 ?g, a vitamin B12 content of at least 0.20 ?g, a folic acid content of at least 20 ?g, a ?-carotene content of at least 100 ?g and a vitamin C content of at least 10 mg. Medium-chain fatty acid oils preferably constitute 35% by weight of the fats of the fat source, per 100 kcal of the composition. The preferred composition viscosity is 6-18 mPa·s (25° C.

Abstract: Disclosed is a nutritive composition for patients being treated with anticancer drugs, which comprises 1-5 mg weight % of a retinoid compound in the solid content of the composition composed of proteins, carbohydrates, fats, vitamins and minerals as major components. It can prevent the immunosuppression induced by the administration of anticancer drugs, and can prevent the infectious diseases arising from said immunosuppression and helps to enhance the therapeutic effect on the patients.